The role of aspirin in primary prevention of CV disease changed for good with results from 3 pivotal trials. Do you recall results and recommendations? Find out.
Aparna Sajja, MD
Advertisement
Articles by Aparna Sajja, MD
What approach is now AHA/ACC guideline-recommended for a patient with primary hypercholesterolemia, with an LDL-C of 192 mg/dL? Take Quiz #3.
How will changes in the AHA/ACC update to the 2013 guidelines help optimize care for patients with ASCVD? Try part 2 of our 3-part quiz and find out.
What's new and what's not in the AHA/ACC 2018 update to the 2013 lipid management guidelines? Try part I of our 3-part quiz and find out.
To Rx or not to Rx aspirin - is one of our 8 questions based on new research that highlights costs vs benefits of aspirin therapy.
Advertisement
Latest Updated Articles
Considering Aspirin: 8 Questions on Primary CVD PreventionPublished: September 2nd 2020 | Updated:
Assessing Aspirin: 8 Questions on Primary CVD PreventionPublished: October 24th 2018 | Updated:
AHA/ACC 2018 Guidelines on Treatment of Blood Cholesterol: Quiz #1Published: January 17th 2019 | Updated:
AHA/ACC 2018 Guidelines on Treatment of Blood Cholesterol: Quiz #2Published: January 24th 2019 | Updated:
Quiz #3: AHA/ACC 2018 Lipid GuidelinesPublished: February 6th 2019 | Updated:
Advertisement
Advertisement
Trending on Patient Care Online
1
Four Studies Build Evidence for Elinzanetant as a Safe, Effective Nonhormonal Option for Menopausal Vasomotor Symptoms
2
Semaglutide CV Effects Appear Independent of Baseline Adiposity, Suggesting Disease-Modifying Potential
3
Elinzanetant Improves Sleep Through VMS-Independent Mechanisms, According to New Pooled Analysis
4
APOE ε4 and Inflammation Amplify Risk for Memory Decline in Women with Earlier Menopause
5
